From: LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL)
Variable | p value |
---|---|
Gender | |
Male versus Female | 0.0658 |
Age (years) | |
≤40y versus >40y | 0.8679 |
Ann Arbor Stage | |
Stage I, II versus Stage III, IV | 0.4129 |
LDH level | |
High versus Normal | 0.7703 |
B symptoms | |
Positive versus Negative | 0.0180* |
IPI | |
L/LI versus HI/H | 0.5418 |
Treatment | |
Single therapy versus Combined therapy | 0.0082* |
LMP1 expression | |
Positive versus Negative | 0.0201* |
LMP2A expression | |
Positive versus Negative | 0.0487* |